Brief Report: Clinical Outcomes Using Plasma-Based Molecular Profiling to Guide Treatment Decisions in Patients With Advanced NSCLC and Limited Access to Broad Tissue TestingMiguel García-Pardo, Antonio Calles, Íñigo Martínez et al.|Clinical Lung Cancer|2023Cited by 4